Innovative Eyewear Inc financial data

Symbol
LUCY, LUCYW on Nasdaq
Industry
Ophthalmic Goods
Location
11900 Biscayne Blvd, Ste 630, Miami, Florida
State of incorporation
Florida
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.15K % +221%
Quick Ratio 125 % +246%
Debt-to-equity 9.34 % -73.6%
Return On Equity -111 % +40.1%
Return On Assets -101 % +25.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 12.9M shares +67.6%
Common Stock, Shares, Outstanding 13.2M shares +71.5%
Entity Public Float 6.92M USD
Common Stock, Value, Issued 132 USD +71.4%
Weighted Average Number of Shares Outstanding, Basic 13M shares +71.1%
Weighted Average Number of Shares Outstanding, Diluted 13M shares +71.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.39M USD +145%
Cost of Revenue 1.51M USD +120%
Research and Development Expense 727K USD +13.6%
Selling and Marketing Expense 2.45M USD +41.3%
General and Administrative Expense 4M USD +25.7%
Nonoperating Income (Expense) 237K USD
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -7.2M USD -22%
Earnings Per Share, Basic -0.59 USD/shares +21.1%
Earnings Per Share, Diluted -0.59 USD/shares +21.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.65M USD -23.2%
Accounts Receivable, after Allowance for Credit Loss, Current 52.8K USD -58.7%
Inventory, Net 859K USD +15.6%
Other Assets, Current 59.4K USD +64%
Assets, Current 4.11M USD -9.5%
Property, Plant and Equipment, Net 143K USD +4.3%
Other Assets, Noncurrent 118K USD +43.2%
Assets 4.81M USD -5.87%
Liabilities, Current 883K USD +75.1%
Liabilities 911K USD +62%
Retained Earnings (Accumulated Deficit) -18.9M USD -61.4%
Stockholders' Equity Attributable to Parent 3.9M USD -14.3%
Liabilities and Equity 4.81M USD -5.87%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.47M USD -7.7%
Net Cash Provided by (Used in) Financing Activities -76K USD -106%
Net Cash Provided by (Used in) Investing Activities -95.5K USD +30.2%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 13.2M shares +71.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.65M USD -23.2%
Deferred Tax Assets, Valuation Allowance 3.73M USD +72.5%
Deferred Tax Assets, Gross 3.73M USD +72.5%
Depreciation 72.4K USD +155%
Payments to Acquire Property, Plant, and Equipment 32.3K USD +14.8%
Lessee, Operating Lease, Liability, to be Paid 14M USD
Property, Plant and Equipment, Gross 246K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 436K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 161K USD +339%
Lessee, Operating Lease, Liability, to be Paid, Year Three 834K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.29M USD
Additional Paid in Capital 22.8M USD +40.2%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 7.81K USD -24.2%
Depreciation, Depletion and Amortization 21.7K USD +264%
Interest Expense 3.04K USD -97.1%